unknown
Stage
2009
Founded
1
Investors
About
Advicenne is a pharmaceutical company that develops and commercializes innovative treatments for rare kidney diseases, with a focus on pediatric populations. Its lead product, Sibnayal, is approved for distal renal tubular acidosis (dRTA).
Explore Advicenne's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.